Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F- Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)

Katherine Cameron, Sivan Golan, William Simpson, Steven Peti, Sasan Roayaie, Daniel Labow, Lale Kostakoglu

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Abstract

Although the current literature is limited, available data suggest that 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) imaging improves the evaluation of patients with recurrent pancreatic carcinoma and cholangiocarcinoma. There is evidence that PET/CT is particularly useful in the setting of elevated tumor markers and negative or equivocal CT findings. This article reviews the nature of these carcinomas in the post-therapy setting and describes the strengths and limitations of PET/CT when used for monitoring recurrence.

Original languageEnglish
Pages (from-to)463-471
Number of pages9
JournalAbdominal Imaging
Volume36
Issue number4
DOIs
StatePublished - Aug 2011

Keywords

  • Cholangiocarcinoma
  • Oncology
  • PET/CT
  • Pancreatic carcinoma
  • Recurrence
  • Restaging

Fingerprint

Dive into the research topics of 'Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F- Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)'. Together they form a unique fingerprint.

Cite this